Evaluation of Attitudes About Fertility

October 12, 2012 updated by: Grupo de Estudios Clínicos Oncológicos Peruano

Evaluation of Attitudes of Premenopausal Latin American Patients With Breast Cancer Towards the Risk of Loss Their Fertility by Chemotherapy

  • Assess the attitudes and feelings of premenopausal Latin American women towards the risk of loss their fertility by adjuvant chemotherapy.
  • Correlate the attitudes with other variables including age at diagnosis, already having children, number of children, level of instruction, marital status, frequency of menstrual cycle.

Study Overview

Status

Unknown

Conditions

Detailed Description

Eligibility criteria:

  • Latin American women with evidence of cancer diagnosis at premenopausal status
  • Over 18 years
  • Agree to sign the informed consent
  • No evidence of infertility.

Study Type

Observational

Enrollment (Anticipated)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Peru
      • Lima, Peru, 34
        • Instituto Nacional de Enfermedades Neoplásicas
      • Lima, Peru, 41
        • Oncosalud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

women with diagnosis of breast cancer in pre menopausal status

Description

Inclusion Criteria:

  • women with breast cancer diagnosis in premenopausal
  • over 18 years
  • signed informed consent

Exclusion Criteria:

  • Evidence of infertility at diagnosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Grupo de Estudios Clínicos Oncológicos Peruano

Collaborators

European Organisation for Research and Treatment of Cancer - EORTC

Investigators

  • Principal Investigator: HENRY L GOMEZ, DR, Grupo de Estudios Clínicos Oncológicos Peruano

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Study Completion (ANTICIPATED)

June 1, 2013

Study Registration Dates

First Submitted

October 10, 2012

First Submitted That Met QC Criteria

October 11, 2012

First Posted (ESTIMATE)

October 12, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

October 15, 2012

Last Update Submitted That Met QC Criteria

October 12, 2012

Last Verified

October 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GECOPERU 01-2012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe